“After several months of collaboration, we are proud to say, GenAmplify version 2, the country’s very own RT-PCR test kit, is finally ready for commercial use,” the DOH said in a statement.
“As with other medical products and devices, performance of the kit will be regularly monitored,” the DOH said. FDA Director General Rolando Enrique Domingo said that they already approved last July 9 the conduct of the clinical trials.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: